PMV Pharmaceuticals: Restoring Mutant P53 Could Create A Mispriced Cancer Opportunity

PMV Pharmaceuticals is working on restoring mutant P53, which could create a mispriced cancer opportunity. The company's research and potential impact are discussed.

Want to stay up to date with the world events at sea or at home?

Explore Navvyx News - the best News app for seafarers.

Join Navvyx - it's Free